Showing results (141-150 of 615) with videos related to
Sort By:
Pageof 62
Developmental Dynamics : an Official Publication of the American Association of Anatomists|March 31, 1998
VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivoX Zeng, S E Wert, R Federici, et al.Obstetrics and Gynecology|July 1, 1987
Surfactant associated protein (SAP-35) in amniotic fluid from diabetic and nondiabetic pregnanciesM J McMahan, F Mimouni, M Miodovnik, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|February 13, 2001
GM-CSF regulates protein and lipid catabolism by alveolar macrophagesM Yoshida, M Ikegami, J A Reed, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|August 25, 2000
Surfactant metabolism in SP-D gene-targeted miceM Ikegami, J A Whitsett, A Jobe, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|August 16, 2001
SP-D and GM-CSF regulate surfactant homeostasis via distinct mechanismsM Ikegami, W M Hull, M Yoshida, et al.The American Journal of Physiology|July 1, 1994
3'-untranslated region of SP-B mRNA mediates inhibitory effects of TPA and TNF-alpha on SP-B expressionG S Pryhuber, S L Church, T Kroft, et al.Biochimica Et Biophysica Acta|April 26, 1989
Effect of surfactant-associated protein-A (SP-A) on the activity of lipid extract surfactantJ Chung, S H Yu, J A Whitsett, et al.Chemistry and Physics of Lipids|December 1, 1991
Effects of surfactant-associated protein SP-B synthetic analogs on the structure and surface activity of model membrane bilayersJ E Baatz, V Sarin, D R Absolom, et al.The American Journal of Physiology|August 12, 1998
Retinoic acid-receptor activation of SP-B gene transcription in respiratory epithelial cellsC Yan, M Ghaffari, J A Whitsett, et al.Expert Opinion on Pharmacotherapy|April 7, 2010
Etravirine in combination with darunavir/ritonavir and optimized background regimen results in suppression of HIV replication in treatment-experienced patients. Evaluation of Katlama C, Haubrich R, Lalezari J, et al. Efficacy and safety of etravirine in treatment-experienced HIV-1 patients: pooled 48-week analysis of two randomized, controlled trials. AIDS 2009; 23: 2289-300Mark W Hull, Julio S G MontanerPageof 62